Items Tagged ‘Management and Prevention of Bone Complications Supportive Care’

November 30, 2010

Xgeva Approved for Patients with Bone Metastases

By

Xgeva™ (denosumab) has been approved by the US Food and Drug Administration (FDA) for the prevention of bone complications such as fracture in patients with bone metastases from solid (not blood-related) cancers. It is not approved for patients with multiple myeloma or other cancers of the blood. Metastatic cancer refers to cancer that has spread […]

View full entry

Tags: Breast Cancer, Management and Prevention of Bone Complications Supportive Care, Metastatic Breast Cancer, Metastatic Stage IV (D) Prostate Cancer, Prostate Cancer, Supportive Care